Opioid Use Disorder in Black Adults: A Treatment-Access Gap

Opioid use disorder (OUD) is a chronic medical condition, not a moral failing or a lack of willpower. Repeated opioid exposure changes the brain circuits that control reward, stress, and self-control, which is why stopping on willpower alone so often fails. The National Institute on Drug Abuse classifies addiction as a treatable brain disorder, and three FDA-approved medications can cut the risk of dying. The hardest part for many Black patients is not wanting treatment. It is getting prescribed the right one.

For most of the opioid epidemic, overdose death rates were higher among white Americans. That flipped. From 2019 to 2020, overdose death rates rose 44% among Black people, faster than any other group, and Black overdose mortality overtook the white rate for the first time in decades. The CDC found the rate among Black men age 65 and older was nearly seven times the rate for white men the same age.

The driver is illicitly manufactured fentanyl, which is dozens of times stronger than heroin and is now mixed into the cocaine, counterfeit pills, and other drug supply that many people do not know they are buying. A 2025 Health Affairs analysis found that roughly 40% of the additional growth in Black overdose deaths compared with white deaths between 2010 and 2020 traced to where people lived: fentanyl saturated the local drug supply in many Black neighborhoods, and the deaths followed. This is a geography-and-supply story, not a behavior story.

There are three FDA-approved medications for OUD: buprenorphine (sold as Suboxone and others), methadone, and naltrexone (Vivitrol). Buprenorphine and methadone are the two that reduce overdose death the most. A Massachusetts cohort study of more than 17,000 people who survived an overdose found that buprenorphine cut deaths by about 38% and methadone by about 59% over the following year, compared with no medication.

Buprenorphine is the medication you can get from an office visit and fill at a pharmacy, which makes it the most convenient and least stigmatizing option for most people. Black patients get it far less often. A national study in JAMA Psychiatry found that compared with white patients, Black patients had 77% lower odds of an office visit that included a buprenorphine prescription, and most buprenorphine visits were paid for with cash or private insurance, not Medicaid. Black patients are more often steered toward daily-dosing methadone clinics or into the criminal-legal system instead of office-based care. The medication that is easiest to live a normal life on is the one Black patients are least likely to be offered.

The barriers continue at the pharmacy counter. Pharmacies in predominantly Black and Latino neighborhoods are less likely to stock buprenorphine and less likely to stock naloxone, even where the need is highest. If you are turned away, that is a supply problem in your zip code, not a judgment on you. Call ahead to other pharmacies, or ask your prescriber to send the script somewhere known to stock it.

Naloxone, best known by the brand name Narcan, is a nasal spray that reverses an opioid overdose within minutes by knocking opioids off the brain's receptors. In March 2023 the FDA approved Narcan for over-the-counter sale, so you can now buy it without a prescription at drugstores, grocery stores, gas stations, and online. Many health departments and community programs give it away free. Keep it where you or someone you love might need it, the same way you keep a smoke detector. It only works on opioids, but it cannot hurt someone who does not have opioids in their system, so when in doubt, use it.

An opioid overdose looks like this: the person will not wake up or respond, breathing is slow, shallow, or stopped, lips or fingertips turn blue or gray, and you may hear gurgling or snoring. On brown and Black skin, the bluish color shows up first on the lips, gums, and nail beds rather than the face, so check there.

If you suspect an overdose, act in this order:

1. Call 911. Say the person is not breathing. Most states have Good Samaritan laws that protect you from drug-possession charges when you call for help.
2. Give naloxone. Spray one dose in one nostril. If there is no response in 2 to 3 minutes, give a second dose.
3. Give rescue breaths if the person is not breathing: tilt the head back, pinch the nose, and give one breath every 5 seconds.
4. Roll them onto their side (the recovery position) so they do not choke if they vomit, and stay until help arrives.

OUD is diagnosed by a pattern, not a single behavior. Common signs include taking opioids in larger amounts or longer than intended, strong cravings, needing more to get the same effect, withdrawal symptoms (sweating, chills, nausea, muscle aches, anxiety) when not using, and continuing to use despite damage to work, relationships, or health. This includes prescription pills, not just heroin or fentanyl. If several of these fit you or someone you love, that is a medical reason to talk to a clinician, not a character flaw to hide.

Treatment is more available than it used to be. In 2023 the federal government removed the X-waiver, the special permission clinicians once needed to prescribe buprenorphine. Now any clinician with a standard DEA registration can prescribe it, which means your primary care doctor, an OB-GYN, or a telehealth provider can start you on it, not just a specialist. You no longer have to find a clinic with a waiver.

Start by calling the SAMHSA National Helpline at 1-800-662-4357 for free, confidential referrals, or ask your regular doctor directly about buprenorphine. If you want a clinician who understands the bias Black patients face in addiction care, you can find a Black or Black-serving provider in our directory. Opioid use disorder and depression often travel together; if low mood is part of the picture, our piece on depression in Black men covers what treatment looks like. Many people also use more than one substance, and our guide to alcohol use disorder in Black adults walks through that overlap.